Search - tctmd.com

Displaying 201 - 220 of 681

Sort: Relevancy | Date

News Conference News AHA 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

L.A. McKeown

November 09, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Conference News AHA 2022

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

Yael L. Maxwell

November 01, 2022

News Daily News

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Caitlin E. Cox

October 31, 2022

News Daily News

Early Data Suggest Plant-Based Foods Could Improve Outcomes in HF

L.A. McKeown

October 26, 2022

News Daily News

Cardiopulmonary Tests in Long COVID Offer Some Clues, Pose More Questions

L.A. McKeown

October 21, 2022

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal Care Resumes

News Daily News

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Michael O'Riordan

October 18, 2022

News Conference News EACTS 2022

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

Michael O'Riordan

October 12, 2022

News Daily News

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

Michael O'Riordan

October 07, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2022

Shelley Wood

September 01, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

News Daily News

CV Symptoms Deserve More Attention, Quantification: AHA Statement

Yael L. Maxwell

August 18, 2022

News Daily News

US, European Hypertension Guidelines: More Alike Than Different

Caitlin E. Cox

August 17, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

Advertisement

China Rural Intervention Still Reaping BP Control Wins at 3 Years

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

Novel Intervention to Increase GDMT in HF Exploits Noncardiac Admissions

STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden

Early Data Suggest Plant-Based Foods Could Improve Outcomes in HF

Cardiopulmonary Tests in Long COVID Offer Some Clues, Pose More Questions

SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes

Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

October 2022 News Roundup

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

TCTMD’s Top 10 Most Popular Stories for August 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

CV Symptoms Deserve More Attention, Quantification: AHA Statement

US, European Hypertension Guidelines: More Alike Than Different

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content